Baseline PSA as a predictor of prostate cancer‐specific mortality over the past 2 decades

Abstract

Baseline PSA appears to be a reliable and independent predictor of death from prostate cancer. A baseline PSA of ≥4 ng/mL has been associated with higher risk of death from prostate cancer.